Ignite Creation Date:
2025-12-24 @ 10:16 PM
Ignite Modification Date:
2026-04-16 @ 3:57 AM
Study NCT ID:
NCT02759835
Status:
COMPLETED
Last Update Posted:
2024-06-07
First Post:
2016-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-06
First Submit QC Date:
None
Study First Post Date:
2016-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-10
Results First Submit QC Date:
None
Results First Post Date:
2023-07-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-13
Last Update Post Date:
2024-06-07
Last Update Post Date Type:
ACTUAL